These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 20538006)
1. The occluding loop of cathepsin B prevents its effective inhibition by human kininogens. Naudin C; Lecaille F; Chowdhury S; Krupa JC; Purisima E; Mort JS; Lalmanach G J Mol Biol; 2010 Jul; 400(5):1022-35. PubMed ID: 20538006 [TBL] [Abstract][Full Text] [Related]
2. The occluding loop in cathepsin B defines the pH dependence of inhibition by its propeptide. Quraishi O; Nägler DK; Fox T; Sivaraman J; Cygler M; Mort JS; Storer AC Biochemistry; 1999 Apr; 38(16):5017-23. PubMed ID: 10213604 [TBL] [Abstract][Full Text] [Related]
3. High molecular weight kininogen as substrate for cathepsin B. Barros NM; Tersariol IL; Oliva ML; Araújo MS; Sampaio CA; Juliano L; Motta G Biol Chem; 2004 Jun; 385(6):551-5. PubMed ID: 15255189 [TBL] [Abstract][Full Text] [Related]
4. Hybrids of chicken cystatin with human kininogen domain 2 sequences exhibit novel inhibition of calpain, improved inhibition of actinidin and impaired inhibition of papain, cathepsin L and cathepsin B. Auerswald EA; Nägler DK; Gross S; Assfalg-Machleidt I; Stubbs MT; Eckerskorn C; Machleidt W; Fritz H Eur J Biochem; 1996 Feb; 235(3):534-42. PubMed ID: 8654398 [TBL] [Abstract][Full Text] [Related]
5. Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts. Nägler DK; Storer AC; Portaro FC; Carmona E; Juliano L; Ménard R Biochemistry; 1997 Oct; 36(41):12608-15. PubMed ID: 9376367 [TBL] [Abstract][Full Text] [Related]
6. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases. Pavlova A; Björk I Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883 [TBL] [Abstract][Full Text] [Related]
7. Human cathepsin B and cysteine proteinase inhibitors (CPIs) in inflammatory and metabolic joint diseases. Lenarcic B; Gabrijelcic D; Rozman B; Drobnic-Kosorok M; Turk V Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():257-61. PubMed ID: 3264507 [TBL] [Abstract][Full Text] [Related]
8. Stefin A displaces the occluding loop of cathepsin B only by as much as required to bind to the active site cleft. Renko M; Požgan U; Majera D; Turk D FEBS J; 2010 Oct; 277(20):4338-45. PubMed ID: 20860624 [TBL] [Abstract][Full Text] [Related]
9. A new purification procedure of human kidney cathepsin H, its properties and kinetic data. Popović T; Brzin J; Kos J; Lenarcic B; Machleidt W; Ritonja A; Hanada K; Turk V Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():175-83. PubMed ID: 3202963 [TBL] [Abstract][Full Text] [Related]
10. Fasciola hepatica: characterization and cloning of the major cathepsin B protease secreted by newly excysted juvenile liver fluke. Wilson LR; Good RT; Panaccio M; Wijffels GL; Sandeman RM; Spithill TW Exp Parasitol; 1998 Feb; 88(2):85-94. PubMed ID: 9538862 [TBL] [Abstract][Full Text] [Related]
11. Structural requirements for cathepsin B and cathepsin H inhibition by kininogens. Bano B; Kunapuli SP; Bradford HN; Colman RW J Protein Chem; 1996 Aug; 15(6):519-25. PubMed ID: 8895098 [TBL] [Abstract][Full Text] [Related]
12. Leishmania major: comparison of the cathepsin L- and B-like cysteine protease genes with those of other trypanosomatids. Sakanari JA; Nadler SA; Chan VJ; Engel JC; Leptak C; Bouvier J Exp Parasitol; 1997 Jan; 85(1):63-76. PubMed ID: 9024203 [TBL] [Abstract][Full Text] [Related]
13. Cystatins as calpain inhibitors: engineered chicken cystatin- and stefin B-kininogen domain 2 hybrids support a cystatin-like mode of interaction with the catalytic subunit of mu-calpain. Díaz BG; Gross S; Assfalg-Machleidt I; Pfeiler D; Gollmitzer N; Gabrijelcic-Geiger D; Stubbs MT; Fritz H; Auerswald EA; Machleidt W Biol Chem; 2001 Jan; 382(1):97-107. PubMed ID: 11258679 [TBL] [Abstract][Full Text] [Related]
14. Kininogen-derived peptides for investigating the putative vasoactive properties of human cathepsins K and L. Desmazes C; Galineau L; Gauthier F; Brömme D; Lalmanach G Eur J Biochem; 2003 Jan; 270(1):171-8. PubMed ID: 12492488 [TBL] [Abstract][Full Text] [Related]
16. Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases. Pol E; Björk I Protein Sci; 2001 Sep; 10(9):1729-38. PubMed ID: 11514663 [TBL] [Abstract][Full Text] [Related]
17. Cathepsin L, but not cathepsin B, is a potential kininogenase. Desmazes C; Gauthier F; Lalmanach G Biol Chem; 2001 May; 382(5):811-5. PubMed ID: 11517935 [TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of inhibition of cysteine proteinases by their protein inhibitors: kinetic studies with natural and recombinant variants of cystatins and stefins. Machleidt W; Thiele U; Assfalg-Machleidt I; Förger D; Auerswald EA Biomed Biochim Acta; 1991; 50(4-6):613-20. PubMed ID: 1801731 [TBL] [Abstract][Full Text] [Related]
19. Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration By release of loop anchoring through mutation of his110. Pavlova A; Krupa JC; Mort JS; Abrahamson M; Björk I FEBS Lett; 2000 Dec; 487(2):156-60. PubMed ID: 11150500 [TBL] [Abstract][Full Text] [Related]
20. Importance of the second binding loop and the C-terminal end of cystatin B (stefin B) for inhibition of cysteine proteinases. Pol E; Björk I Biochemistry; 1999 Aug; 38(32):10519-26. PubMed ID: 10441148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]